Defrijet 500

Defrijet 500mg Tablet is a medication classified as an iron chelator, containing the active ingredient Deferasirox. It is utilized to manage chronic iron overload resulting from transfusion-dependent anemias, such as beta-thalassemia and specific myelodysplastic syndromes. In these conditions, iron overload can arise due to frequent blood transfusions, resulting in excessive iron buildup in the body.

If you notice any signs of allergies, ulcers, skin reactions, or bleeding while undergoing this treatment, contact your doctor immediately. Throughout the treatment, your physician may regularly check your blood counts, serum creatinine levels, and liver function to avert serious complications. Defrijet 500mg Tablet is not advised for individuals with poor performance status, myelodysplastic syndrome, advanced cancer, or a GFR below 40ml/min/1.73m2. If you experience any changes in vision, seek emergency medical attention from your healthcare provider.

It is generally advised to refrain from using Defrijet 500mg Tablet during pregnancy and breastfeeding. Inform your doctor if you are pregnant, nursing, or planning to conceive. Patients are encouraged to use effective non-hormonal contraception while receiving treatment with this medication to avoid unintended pregnancy. This drug should not be administered to individuals with severe kidney or liver dysfunction and should be used with caution in those with existing kidney or liver issues.